Previous 10 | Next 10 |
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha , iTunes , Stitcher and Spotify . Economic reports in the week ahead Investors will have their eyes on economic reports covering construction spending, manufacturing a...
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , Apple ...
AcelRx Pharmaceuticals ( ACRX -0.9% ) announced an investigator-initiated study with Cleveland Clinic to assess the effects of DSUVIA on post-operative recovery from orthopedic surgery. More news on: AcelRx Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move, Rea...
REDWOOD CITY, Calif. , Aug. 24, 2020 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in healthcare institutions, today announced an inves...
AcelRx Pharmaceuticals ( ACRX +6.0% ) announces the publication of a study that supports the benefit of Dsuvia (sufentanil sublingual tablet) administered before surgery. More news on: AcelRx Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move, Read more ...
REDWOOD CITY, Calif. , Aug. 19, 2020 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today announced the publication of a stud...
I have covered AcelRx Pharmaceuticals ( ACRX ) before, so investors should view this as an update to my previous articles . Well, that was one busy quarter for ACRX, wasn't it? Here is what happened since the last financial statements were issued: Grünenthal terminated th...
Fennec Pharmaceuticals (NASDAQ: FENC ) -31% on FDA rejection of Pedmark application. More news on: Fennec Pharmaceuticals Inc., Mesoblast Limited, Genesis Healthcare, Inc., Stocks on the move, , Read more ...
AcelRx Pharmaceuticals, Inc. (ACRX) Q2 2020 Earnings Conference Call August 10, 2020, 16:30 ET Company Participants Raffi Asadorian - CFO Vincent Angotti - CEO & Director Pamela Palmer - Co-Founder, Chief Medical Officer & Director Conference Call Participants Brand...
REDWOOD CITY, Calif. , Aug. 10, 2020 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today reported its second quart...
News, Short Squeeze, Breakout and More Instantly...
AcelRx Pharmaceuticals Inc. Company Name:
ACRX Stock Symbol:
NASDAQ Market:
AcelRx Pharmaceuticals Inc. Website:
AcelRx Announces Rebranding With Name Change to Talphera, Inc. PR Newswire Name change to "Talphera" reflects a new era of the Company in partnership with the medical community developing novel solutions for medically supervised settings Talphera will begin trading on ...
AcelRx Pharmaceuticals Announces Publication of Study Evaluating Anticoagulation Practices for Continuous Renal Replacement Therapy in the United States PR Newswire Use of CRRT increased during COVID and remained at these higher utilization levels Study results demonst...
AcelRx Reports Third Quarter 2023 Financial Results and Provides Corporate Update PR Newswire Niyad™ Investigational Device Exemption (IDE) approval by the FDA achieved in third quarter Company plans to begin its Niyad registrational study this quarter with topl...